Bruton tyrosine kinase (BTK) inhibitors have become a mainstay of treatment for relapsed or refractory (R/R) mantle cell ...
Lilly opens early access to retatrutide for some patients before FDA approval, following scrutiny over a single earlier compassionate-use case. A source familiar with Lilly's program told STAT that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results